Impax Asset Management Group PLC Abb Vie Inc. Transaction History

Impax Asset Management Group PLC

$23 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Nov 08, 2024	BUY	$154.79 - $180.76 $588,202 - $686,888	3,800 New	3,800 $651,000
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $4.55 Million - $5.31 Million	-29,364 Reduced 88.54%	3,800 $651,000
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $529,004 - $602,751	-3,310 Reduced 9.07%	33,164 $6.04 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $2.54 Million - $2.86 Million	-18,465 Reduced 33.61%	36,474 $5.65 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $1.27 Million - $1.47 Million	-9,506 Reduced 14.75%	54,939 $8.19 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $181,273 - $225,583	1,368 Added 2.17%	64,445 $8.68 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $87,922 - $101,256	-608 Reduced 0.95%	63,077 $10.1 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $1.1 Million - $1.32 Million	-7,935 Reduced 11.08%	63,685 $10.3 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $532,008 - $610,178	-3,964 Reduced 5.24%	71,620 $9.61 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $556,122 - $707,013	-4,041 Reduced 5.08%	75,584 $11.6 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $393,828 - $488,630	2,984 Added 3.89%	79,625 $12.9 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $351,618 - $444,898	-3,273 Reduced 4.1%	76,641 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $21,386 - $24,276	201 Added 0.25%	79,914 $8.62 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $526 - $586	5 Added 0.01%	79,713 $8.98 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $2.68 Million - $2.95 Million	26,201 Added 48.97%	79,708 $8.63 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $4.31 Million - $5.81 Million	53,507 New	53,507 $5.73 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account